The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bipolar Disorder Therapeutics Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Bipolar Disorder Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bipolar Disorder Therapeutics Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. lumateperone accounting for % of the Bipolar Disorder Therapeutics Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Olanzapine (Zyprexa) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bipolar Disorder Therapeutics Drugs include AstraZeneca, Allergan, Bristol-Myers Squibb, GSK, and Janssen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bipolar Disorder Therapeutics Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ariprazole (Abilify)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Market segment by Application can be divided into
lumateperone
Central Nervous System (CNS) Disorders
The key market players for global Bipolar Disorder Therapeutics Drugs market are listed below:
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bipolar Disorder Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bipolar Disorder Therapeutics Drugs, with price, sales, revenue and global market share of Bipolar Disorder Therapeutics Drugs from 2019 to 2022.
Chapter 3, the Bipolar Disorder Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bipolar Disorder Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bipolar Disorder Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bipolar Disorder Therapeutics Drugs.
Chapter 13, 14, and 15, to describe Bipolar Disorder Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Bipolar Disorder Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bipolar Disorder Therapeutics Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. lumateperone accounting for % of the Bipolar Disorder Therapeutics Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Olanzapine (Zyprexa) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bipolar Disorder Therapeutics Drugs include AstraZeneca, Allergan, Bristol-Myers Squibb, GSK, and Janssen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bipolar Disorder Therapeutics Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ariprazole (Abilify)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Market segment by Application can be divided into
lumateperone
Central Nervous System (CNS) Disorders
The key market players for global Bipolar Disorder Therapeutics Drugs market are listed below:
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bipolar Disorder Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bipolar Disorder Therapeutics Drugs, with price, sales, revenue and global market share of Bipolar Disorder Therapeutics Drugs from 2019 to 2022.
Chapter 3, the Bipolar Disorder Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bipolar Disorder Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bipolar Disorder Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bipolar Disorder Therapeutics Drugs.
Chapter 13, 14, and 15, to describe Bipolar Disorder Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Bipolar Disorder Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bipolar Disorder Therapeutics Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Olanzapine (Zyprexa)
1.2.3 Quetiapine (Seroquel)
1.2.4 Risperidone (Risperdal)
1.2.5 Ariprazole (Abilify)
1.2.6 Ziprasidone (Geodon)
1.2.7 Clozapine (Clozaril)
1.3 Market Analysis by Application
1.3.1 Overview: Global Bipolar Disorder Therapeutics Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 lumateperone
1.3.3 Central Nervous System (CNS) Disorders
1.4 Global Bipolar Disorder Therapeutics Drugs Market Size & Forecast
1.4.1 Global Bipolar Disorder Therapeutics Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bipolar Disorder Therapeutics Drugs Sales in Volume (2017-2028)
1.4.3 Global Bipolar Disorder Therapeutics Drugs Price (2017-2028)
1.5 Global Bipolar Disorder Therapeutics Drugs Production Capacity Analysis
1.5.1 Global Bipolar Disorder Therapeutics Drugs Total Production Capacity (2017-2028)
1.5.2 Global Bipolar Disorder Therapeutics Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bipolar Disorder Therapeutics Drugs Market Drivers
1.6.2 Bipolar Disorder Therapeutics Drugs Market Restraints
1.6.3 Bipolar Disorder Therapeutics Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Product and Services
2.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Bipolar Disorder Therapeutics Drugs Product and Services
2.2.4 Allergan Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product and Services
2.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Bipolar Disorder Therapeutics Drugs Product and Services
2.4.4 GSK Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Janssen
2.5.1 Janssen Details
2.5.2 Janssen Major Business
2.5.3 Janssen Bipolar Disorder Therapeutics Drugs Product and Services
2.5.4 Janssen Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Product and Services
2.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Youdim
2.7.1 Youdim Details
2.7.2 Youdim Major Business
2.7.3 Youdim Bipolar Disorder Therapeutics Drugs Product and Services
2.7.4 Youdim Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Delpor
2.8.1 Delpor Details
2.8.2 Delpor Major Business
2.8.3 Delpor Bipolar Disorder Therapeutics Drugs Product and Services
2.8.4 Delpor Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Lundbeck
2.9.1 Lundbeck Details
2.9.2 Lundbeck Major Business
2.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Product and Services
2.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Intra-Cellular Therapies
2.10.1 Intra-Cellular Therapies Details
2.10.2 Intra-Cellular Therapies Major Business
2.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product and Services
2.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novartis Pharmaceuticals Corporation
2.11.1 Novartis Pharmaceuticals Corporation Details
2.11.2 Novartis Pharmaceuticals Corporation Major Business
2.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product and Services
2.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Noven Pharmaceuticals
2.12.1 Noven Pharmaceuticals Details
2.12.2 Noven Pharmaceuticals Major Business
2.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
2.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Otsuka
2.13.1 Otsuka Details
2.13.2 Otsuka Major Business
2.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Product and Services
2.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Product and Services
2.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Reviva Pharmaceuticals
2.15.1 Reviva Pharmaceuticals Details
2.15.2 Reviva Pharmaceuticals Major Business
2.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
2.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bipolar Disorder Therapeutics Drugs Breakdown Data by Manufacturer
3.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bipolar Disorder Therapeutics Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Bipolar Disorder Therapeutics Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Bipolar Disorder Therapeutics Drugs Manufacturer Market Share in 2021
3.5 Global Bipolar Disorder Therapeutics Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bipolar Disorder Therapeutics Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Region
4.1.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2028)
4.2 North America Bipolar Disorder Therapeutics Drugs Revenue (2017-2028)
4.3 Europe Bipolar Disorder Therapeutics Drugs Revenue (2017-2028)
4.4 Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue (2017-2028)
4.5 South America Bipolar Disorder Therapeutics Drugs Revenue (2017-2028)
4.6 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Type (2017-2028)
5.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2028)
5.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Application (2017-2028)
6.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2028)
6.3 Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
7.2 North America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
7.3 North America Bipolar Disorder Therapeutics Drugs Market Size by Country
7.3.1 North America Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
8.2 Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
8.3 Europe Bipolar Disorder Therapeutics Drugs Market Size by Country
8.3.1 Europe Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Bipolar Disorder Therapeutics Drugs Market Size by Region
9.3.1 Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
10.2 South America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
10.3 South America Bipolar Disorder Therapeutics Drugs Market Size by Country
10.3.1 South America Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Bipolar Disorder Therapeutics Drugs Market Size by Country
11.3.1 Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bipolar Disorder Therapeutics Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bipolar Disorder Therapeutics Drugs
12.3 Bipolar Disorder Therapeutics Drugs Production Process
12.4 Bipolar Disorder Therapeutics Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bipolar Disorder Therapeutics Drugs Typical Distributors
13.3 Bipolar Disorder Therapeutics Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Bipolar Disorder Therapeutics Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bipolar Disorder Therapeutics Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Bipolar Disorder Therapeutics Drugs Product and Services
Table 6. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Bipolar Disorder Therapeutics Drugs Product and Services
Table 10. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product and Services
Table 14. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GSK Basic Information, Manufacturing Base and Competitors
Table 16. GSK Major Business
Table 17. GSK Bipolar Disorder Therapeutics Drugs Product and Services
Table 18. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Janssen Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Major Business
Table 21. Janssen Bipolar Disorder Therapeutics Drugs Product and Services
Table 22. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Bipolar Disorder Therapeutics Drugs Product and Services
Table 26. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Youdim Basic Information, Manufacturing Base and Competitors
Table 28. Youdim Major Business
Table 29. Youdim Bipolar Disorder Therapeutics Drugs Product and Services
Table 30. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Delpor Basic Information, Manufacturing Base and Competitors
Table 32. Delpor Major Business
Table 33. Delpor Bipolar Disorder Therapeutics Drugs Product and Services
Table 34. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 36. Lundbeck Major Business
Table 37. Lundbeck Bipolar Disorder Therapeutics Drugs Product and Services
Table 38. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Intra-Cellular Therapies Basic Information, Manufacturing Base and Competitors
Table 40. Intra-Cellular Therapies Major Business
Table 41. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product and Services
Table 42. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Novartis Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Pharmaceuticals Corporation Major Business
Table 45. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product and Services
Table 46. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Noven Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Noven Pharmaceuticals Major Business
Table 49. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
Table 50. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Otsuka Basic Information, Manufacturing Base and Competitors
Table 52. Otsuka Major Business
Table 53. Otsuka Bipolar Disorder Therapeutics Drugs Product and Services
Table 54. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Bipolar Disorder Therapeutics Drugs Product and Services
Table 58. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Reviva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Reviva Pharmaceuticals Major Business
Table 61. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
Table 62. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Bipolar Disorder Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Bipolar Disorder Therapeutics Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Bipolar Disorder Therapeutics Drugs Production Site of Key Manufacturer
Table 68. Bipolar Disorder Therapeutics Drugs New Entrant and Capacity Expansion Plans
Table 69. Bipolar Disorder Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 70. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 71. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2023-2028) & (K Units)
Table 72. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 75. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 76. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2022) & (USD/Unit)
Table 79. Global Bipolar Disorder Therapeutics Drugs Price by Type (2023-2028) & (USD/Unit)
Table 80. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2022) & (USD/Unit)
Table 85. Global Bipolar Disorder Therapeutics Drugs Price by Application (2023-2028) & (USD/Unit)
Table 86. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 87. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 88. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 91. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 92. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 93. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 95. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 96. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 99. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 100. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 110. South America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 111. South America Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 112. South America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 115. South America Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 116. South America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 117. South America Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 126. Bipolar Disorder Therapeutics Drugs Raw Material
Table 127. Key Manufacturers of Bipolar Disorder Therapeutics Drugs Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Bipolar Disorder Therapeutics Drugs Typical Distributors
Table 131. Bipolar Disorder Therapeutics Drugs Typical Customers
List of Figures
Figure 1. Bipolar Disorder Therapeutics Drugs Picture
Figure 2. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type in 2021
Figure 3. Olanzapine (Zyprexa)
Figure 4. Quetiapine (Seroquel)
Figure 5. Risperidone (Risperdal)
Figure 6. Ariprazole (Abilify)
Figure 7. Ziprasidone (Geodon)
Figure 8. Clozapine (Clozaril)
Figure 9. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application in 2021
Figure 10. lumateperone
Figure 11. Central Nervous System (CNS) Disorders
Figure 12. Global Bipolar Disorder Therapeutics Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Bipolar Disorder Therapeutics Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Bipolar Disorder Therapeutics Drugs Sales (2017-2028) & (K Units)
Figure 15. Global Bipolar Disorder Therapeutics Drugs Price (2017-2028) & (USD/Unit)
Figure 16. Global Bipolar Disorder Therapeutics Drugs Production Capacity (2017-2028) & (K Units)
Figure 17. Global Bipolar Disorder Therapeutics Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Bipolar Disorder Therapeutics Drugs Market Drivers
Figure 19. Bipolar Disorder Therapeutics Drugs Market Restraints
Figure 20. Bipolar Disorder Therapeutics Drugs Market Trends
Figure 21. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturer in 2021
Figure 22. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Manufacturer in 2021
Figure 23. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Bipolar Disorder Therapeutics Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Bipolar Disorder Therapeutics Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 27. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2028)
Figure 28. North America Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Europe Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 31. South America Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2028)
Figure 42. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2028)
Figure 43. United States Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2028)
Figure 49. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2028)
Figure 50. Germany Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2028)
Figure 59. China Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 66. South America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 67. South America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2028)
Figure 68. South America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Bipolar Disorder Therapeutics Drugs in 2021
Figure 80. Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
Figure 81. Bipolar Disorder Therapeutics Drugs Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
